78 related articles for article (PubMed ID: 6102031)
1. Disposition of all-trans- and 13-cis-retinoic acids and n-hydroxyethylretinamide in mice after intravenous administration.
Wang CC; Campbell S; Furner RL; Hill DL
Drug Metab Dispos; 1980; 8(1):8-11. PubMed ID: 6102031
[TBL] [Abstract][Full Text] [Related]
2. Disposition of 13-cis-retinoic acid and N-(2-hydroxyethyl)retinamide in mice after oral doses.
Kalin JR; Wells MJ; Hill DL
Drug Metab Dispos; 1982; 10(4):391-8. PubMed ID: 6126340
[TBL] [Abstract][Full Text] [Related]
3. Disposition of all-trans-retinoic acid in mice following oral doses.
Kalin JR; Starling ME; Hill DL
Drug Metab Dispos; 1981; 9(3):196-201. PubMed ID: 6113925
[TBL] [Abstract][Full Text] [Related]
4. Steady state pharmacokinetics of oral treatment with 13-cis-retinoic acid or all-trans-retinoic acid in male and female adult rats.
Ferguson SA; Siitonen PH; Cisneros FJ; Gough B; Young JF
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):582-7. PubMed ID: 16700821
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 13-cis-, all-trans-, 13-cis-4-oxo-, and all-trans-4-oxo retinoic acid after intravenous administration in the cynomolgus monkey.
Sandberg JA; Eckhoff C; Nau H; Slikker W
Drug Metab Dispos; 1994; 22(1):154-60. PubMed ID: 8149876
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic assessment of teratologically effective concentrations of an endogenous retinoic acid metabolite.
Satre MA; Penner JD; Kochhar DM
Teratology; 1989 Apr; 39(4):341-8. PubMed ID: 2749577
[TBL] [Abstract][Full Text] [Related]
7. Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein.
Adamson PC; Boylan JF; Balis FM; Murphy RF; Godwin KA; Gudas LJ; Poplack DG
Cancer Res; 1993 Feb; 53(3):472-6. PubMed ID: 8381046
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of albumin, triglycerides, total protein and glucose in rats are altered after oral treatment with low doses of 13-cis-retinoic acid or all-trans-retinoic acid.
Cisneros FJ; Gough BJ; Patton RE; Ferguson SA
J Appl Toxicol; 2005; 25(6):470-8. PubMed ID: 16092084
[TBL] [Abstract][Full Text] [Related]
9. Distribution and metabolism of the retinoid, N-(4-methoxyphenyl)-all-trans-retinamide, the major metabolite of N-(4-hydroxyphenyl)-all-trans-retinamide, in female mice.
Hultin TA; Filla MS; McCormick DL
Drug Metab Dispos; 1990; 18(2):175-9. PubMed ID: 1971569
[TBL] [Abstract][Full Text] [Related]
10. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.
Shirley MA; Bennani YL; Boehm MF; Breau AP; Pathirana C; Ulm EH
Drug Metab Dispos; 1996 Mar; 24(3):293-302. PubMed ID: 8820419
[TBL] [Abstract][Full Text] [Related]
11. Identification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos.
Tzimas G; Sass JO; Wittfoht W; Elmazar MM; Ehlers K; Nau H
Drug Metab Dispos; 1994; 22(6):928-36. PubMed ID: 7895612
[TBL] [Abstract][Full Text] [Related]
12. Xenopus laevis: a model system for the study of embryonic retinoid metabolism. III. Isomerization and metabolism of all-trans-retinoic acid and 9-cis-retinoic acid and their dysmorphogenic effects in embryos during neurulation.
Kraft JC; Juchau MR
Drug Metab Dispos; 1995 Oct; 23(10):1058-71. PubMed ID: 8654193
[TBL] [Abstract][Full Text] [Related]
13. Identification of 4-oxo-13-cis-retinoic acid as the major metabolite of 13-cis-retinoic acid in human blood.
Vane FM; Buggé CJ
Drug Metab Dispos; 1981; 9(6):515-20. PubMed ID: 6120808
[TBL] [Abstract][Full Text] [Related]
14. N-(4-hydroxyphenyl)-all-trans-retinamide pharmacokinetics in female rats and mice.
Hultin TA; May CM; Moon RC
Drug Metab Dispos; 1986; 14(6):714-7. PubMed ID: 2877832
[TBL] [Abstract][Full Text] [Related]
15. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits.
Eckhoff C; Chari S; Kromka M; Staudner H; Juhasz L; Rudiger H; Agnish N
Toxicol Appl Pharmacol; 1994 Mar; 125(1):34-41. PubMed ID: 8128493
[TBL] [Abstract][Full Text] [Related]
16. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.
Collins MD; Tzimas G; Hummler H; Bürgin H; Nau H
Toxicol Appl Pharmacol; 1994 Jul; 127(1):132-44. PubMed ID: 8048045
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of all-trans-retinoic acid in rat testis.
Chaudhary LR; Nelson EC
Int J Vitam Nutr Res; 1985; 55(1):17-23. PubMed ID: 3997394
[TBL] [Abstract][Full Text] [Related]
18. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
20. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
